Dyax Corp. To Participate In The 2014 Leerink Global Healthcare Conference

Dyax Corp. (NASDAQ:DYAX) announced today that executive management will participate in the 2014 Leerink Global Healthcare Conference being held February 12-13, 2014 at the Waldorf Astoria in New York City. On Wednesday, February 12 at 11:05AM (ET), Gustav Christensen, President and Chief Executive Officer, will participate in a fireside chat to discuss the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio.

This presentation will be webcast live and may be accessed by visiting the Investor Relations section of the company website at www.dyax.com. The webcast will also be available on the Dyax website for a limited period of time following the conference.

Dyax, the Dyax logo and KALBITOR are registered marks of Dyax Corp.

Copyright Business Wire 2010

If you liked this article you might like

Shire to Acquire Biopharma Company Baxalta in $32B Deal

Shire to Acquire Biopharma Company Baxalta in $32B Deal

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

3 Drugs Stocks Moving The Industry Upward

3 Drugs Stocks Moving The Industry Upward

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

OPEC Begins Meeting Today, Saudis May Cut Oil Production

OPEC Begins Meeting Today, Saudis May Cut Oil Production